The Bioxyne Ltd (ASX: BXN) share price has continued its impressive run on Friday and is up a further 63% to 14 cents.
This means the Australian life sciences and health products company's shares have now climbed a remarkable 250% just this week.
What happened?
Investors have been fighting to get hold of Bioxyne's shares since it announced the launch of three health and wellness products into the South East Asia market following the receipt of a direct selling licence for Malaysia.
The key product in its arsenal is its BK18 dairy based nutritional product. The nutritional health drink for the whole family includes an immune boosting probiotic and a range of key vitamins.
The dairy base of the product comes from the world-renowned dairy region of Waikato, New Zealand. Management appears to believe that this will be a major selling point given the popularity of produce from the region.
So far the signs have been positive. According to yesterday's release, an initial 16,000 can order has been received for BK18 from South East Asia markets excluding Malaysia. And with marketing of its products underway in Malaysia now, investors appear to be betting that demand from that market will be strong.
Should you invest?
While I think it is a little soon to know whether the company will follow in the footsteps of A2 Milk Company Ltd (ASX: A2M), Bellamy's Australia Ltd (ASX: BAL), and Blackmores Limited (ASX: BKL), I do intend to keep a close eye on its progress in 2018 and would suggest investors add it to their watch list.
